Excellence in Research webinar series

Your trusted resource for the world’s largest and most diverse collection of human and animal cell lines, microorganisms, biological products, standards, and custom services announces the 2016 Excellence in Research webinar series. The series will showcase the implementation of leading technologies,  the importance of standards, and the application of new ATCC products and  services to advance your scientific research. The webinars will broadcast live for 30 to 45 minutes and will be followed by a 10 minute question and answer  period. Register to join the webinar that best meets your schedule.

Get Ready for a Better Angiogenesis Model

Kevin Grady, B.S., Product Line Business Manager, ATCC
August 4, 2016

Abstract: Angiogenesis is a multi-step physiological process that is involved in a large number of normal and disease state processes. In this webinar, we will introduce the Angio-Ready™ Angiogenesis Assay System, an in vitro co-culture system for measuring angiogenesis, which consists of an assay-ready mixture of an hTERT-immortalized human aortic endothelial cell line (TeloHAEC-GFP) and an hTERT-immortalized adipose-derived mesenchymal stem cell line (hTERT-MSC) in a specially formulated medium. Both cell lines have been well-characterized to verify that they retain the most important characteristics of their parental counterparts. The new co-culture system forms functional tubular structures in less than 7 days and responds appropriately in a dose-dependent manner to known agonists and inhibitors of angiogenesis. Thus, Angio-Ready™ is a ready-to-use, time-saving, high-throughput model for screening drugs or biomolecules for their effect on angiogenesis in cancer, toxicology, diabetes, cardiovascular disease, wound healing, and other pathologies. 

Key points:

  • Angio-Ready™ is a ready-to-use, scalable assay system for angiogenesisis
  • Live imaging is possible with this in vivo-like model consisting of fine tubular structures formed in less than 7 days
  • The formation of vascular tubules responds appropriately to agonists and inhibitors of angiogenesis
Biography: 

Kevin Grady is the Product Line Business Manager for Cell Biology at ATCC. He has been with ATCC for 4 years; prior to ATCC, he held positions at Lonza as Worldwide Product Manager and Director of Scientific Support. Kevin has a long history in the life science industry additionally serving as Director of Scientific Support at Amaxa and Manager of Technical Support at Life Technologies. Mr. Grady has always found great satisfaction in helping researchers learn how to use available products and tools to be more productive and successful in reaching their research goals.

Register for this session 12:00 PM ET.


Improving the Detection of Shiga Toxin-producing Escherichia coli

Cara Wilder, Ph.D., Technical Writer, ATCC
August 18, 2016

Abstract: In the food industry, providing safe products and protecting the company brand is of the utmost importance. To help food manufacturers, processors, and contract testing laboratories ensure the safety of consumable goods, ATCC offers an expanding portfolio of quality control strains to help support the routine verification of raw beef manufacturing trimmings for Shiga toxin-producing Escherichia coli (STEC). In this presentation, we will discuss the growing concern on food-borne illnesses, the importance of quality control strains in food safety, and ATCC STEC reference materials that support this need.

Key points:

  • Food-borne illnesses are a widespread problem that affect tens of millions of people throughout the United States every year
  • ATCC acquires, authenticates, and distributes clinically relevant food-borne pathogens that are essential for use as quality controls in food safety programs
  • Toxigenic, non-toxigenic, and reporter-labeled STEC strains are available from ATCC

Biography: 

Dr. Wilder is the Technical Writer for ATCC Microbial Systems. She has a Ph.D. in Microbiology with background experience working with several pathogenic bacterial species in both in vitro and in vivo environments. Dr. Wilder is the author of numerous publications on varying topics of scientific relevance, including quality control, microbial contamination, assay development, proficiency testing, and multidrug resistance.

Register for this session 12:00 PM ET.


Browse and view past webinars ON DEMAND

Corning Logo- Free online cell culture and assay training webinars